Healthcare -
Biotechnology - NASDAQ - US
$ 9.705
0.674 %
$ 2.9 B
Market Cap
-28.54
P/E
FOLD - STOCK-BASED COMPENSATION
Stock-based Compensation FOLD - Amicus Therapeutics, Inc.
86.1 M
LAST VALUE
21.99%
2 YEAR CAGR
24.09%
5 YEAR CAGR
30.14%
10 YEAR CAGR